Martin Glen - Profile and Investment Details

Investor Profile

Martin Glen is a Venture Capital, Investor based in Greater London, England, United Kingdom with a diverse investment portfolio that includes companies such as M-Spin, Nu Quantum, 1715Labs, Legislate Technologies, Porotech, YASA, Opsydia, Proxisense, Creavo Medical Technologies, Istesso, AudioTelligence, Quantum Motion Technologies, Duel, Bramble Energy, Entia, Nyobolt, DIOSynVax, Salunda, CytoseekNozzle.ai, Ceryx Medical, Oxford Flow, Mind Foundry, MediaGamma, Silicon MicroGravity, Lumenisity, PSYOMICS LTD, PolyProx, Oxford Endovascular, Arkivum, PhoreMost, Zentraxa, Symetrica, Oxbotica, GaitQ, Mirriad, PredictImmune, Undo, Kvasir Analytics, Ilika, GeoSpock, RoboK, Ikarovec, Qkine, NoBACZ, Cambridge GaN Devices, Inkpath, Psyomics, Echopoint Medical, Charco Neurotech, Inflowmatix, Cytora, Congenica, Fuel3D, Gripable, Perpetuum, Aqdot, PharmEnable, Phasecraft, Cambridge Touch Technologies Ltd., LettUs Grow, Mogrify, Inductosense, Xampla, PervasID, Parkwalk Advisors, Echion Technologies, PetMedix, MoA Technology Ltd, Riverlane, Wayland Additive, Flusso, Paragraf, Carbometrics, Cambridge Photon Technology, Covatic, Sorex Sensors, . Over time, Martin Glen has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Martin Glen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Digital Therapeutics, Hospitals, Medication Adherence, E-commerce, Wellness, Chemical, Life Science, Rehabilitation, Artificial Intelligence (AI), Information Technology (IT), Technology, Bioinformatics, Software, Biotechnology, Medical Devices, FinTech, Consumer Internet, Hardware, Health Diagnostics, UK-based Startups, Digital Health, Medical, Big Data, Information Technology, B2B, Therapeutics, Quantum Computing, Pharmaceuticals may find it worthwhile to explore potential connections with Martin Glen, as their portfolio suggests a familiarity and interest in this area.

Understanding Martin Glen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.